Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States

Abstract Background The potential association of long‐term oral corticosteroid (OCS) use with adverse events (AEs) in patients with bullous pemphigoid (BP) is not well characterized in a real‐world setting. Objectives To evaluate the effect of OCS use and treatment duration on the incident AEs in pa...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jonathan I. Silverberg, Feifei Yang, Evo Alemao, Jing Zhao, Concetta Crivera, Hetal V. Patel, Iris Lin, Aaron R. Mangold
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-09-01
Saila:	JEADV Clinical Practice
Gaiak:	autoimmune bullous disease bullous disorders immunobullous disease outcomes research pemphigoid
Sarrera elektronikoa:	https://doi.org/10.1002/jvc2.444
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!